Zai Lab Stock Analysis


USD 44.73  0.48  1.06%   

The current price rise of Zai Lab may raise some interest from investors as it is trading at a share price of 44.73 on 298,076 in trading volume. The company management teams may have good odds in positioning the company resources to exploit market volatility in September. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.14. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Zai Lab partners.
Check out Your Current Watchlist.
The Zai Lab stock analysis report makes it easy to digest most publicly released information about Zai Lab and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Zai Lab Stock analysis module also helps to analyze the Zai Lab price relationship with some important fundamental indicators such as market cap and management efficiency.

Zai Lab Stock Analysis Notes

About 74.0% of the company outstanding shares are owned by institutional investors. The book value of Zai Lab was at this time reported as 16.67. The company recorded a loss per share of 6.25. Zai Lab had not issued any dividends in recent years. Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China. Zai Lab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1951 people. For more information please call the company at 86 21 6163 2588 or visit

Zai Lab Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Zai Lab's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Zai Lab or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Zai Lab is way too risky over 90 days horizon
Zai Lab appears to be risky and price may revert if volatility continues
Zai Lab has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 170.93 M. Net Loss for the year was (553.96 M) with loss before overhead, payroll, taxes, and interest of (481.23 M).
Zai Lab currently holds about 1.31 B in cash with (466.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.41.
Roughly 74.0% of the company outstanding shares are owned by institutional investors
Latest headline from Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia - Yahoo Finance

Zai Lab Thematic Classifications

In addition to having Zai Lab stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

Zai Lab Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Zai Lab is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zai Lab backward and forwards among themselves. Zai Lab's institutional investor refers to the entity that pools money to purchase Zai Lab's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Segantii Capital Management LtdCommon Shares2.2 M77.7 M
Genesis Investment Management LlpCommon Shares1.6 M55.8 M
Baillie Gifford CoCommon Shares737.2 K25.5 M
Russell Investments Group LtdCommon Shares310.6 K10.8 M
Zeal Asset Management LtdCommon Shares288.2 K9.7 M
Privium Fund Management BvCommon Shares248.4 K8.6 M
Sumitomo Mitsui Trust Holdings IncCommon Shares199.5 K6.9 M
Note, although Zai Lab's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Zai Lab Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 4.63 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zai Lab's market, we take the total number of its shares issued and multiply it by Zai Lab's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (26.25) % which means that it has lost $26.25 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (47.8) %, meaning that it created substantial loss on money invested by shareholders. Zai Lab management efficiency ratios could be used to measure how well zai lab manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 10th of August, Zai Lab maintains the Downside Deviation of 6.35, mean deviation of 4.74, and Market Risk Adjusted Performance of 0.419. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zai Lab, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to analyze nineteen technical drivers for Zai Lab, which can be compared to its rivals. Please check out Zai Lab value at risk, and the relationship between the jensen alpha and semi variance to decide if Zai Lab is priced fairly, providing market reflects its latest price of 44.73 per share. Given that Zai Lab has jensen alpha of 0.5831, we strongly advise you to confirm Zai Lab's prevalent market performance to make sure the company can sustain itself at a future point.

Zai Lab Price Movement Analysis

The output start index for this execution was two with a total number of output elements of fifty-nine. The Simple Moving Average indicator is calculated by adding the closing price of Zai Lab for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Zai Lab short-term fluctuations and highlight longer-term trends or cycles.

Zai Lab Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zai Lab insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zai Lab's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zai Lab insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Zai Lab Predictive Daily Indicators

Zai Lab intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zai Lab stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Zai Lab Forecast Models

Zai Lab time-series forecasting models is one of many Zai Lab's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zai Lab's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Zai Lab Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Zai Lab stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zai Lab shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Zai Lab. By using and applying Zai Lab Stock analysis, traders can create a robust methodology for identifying Zai Lab entry and exit points for their positions.
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China. Zai Lab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1951 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Zai Lab to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Comparator Now


Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module
Check out Your Current Watchlist. Note that the Zai Lab information on this page should be used as a complementary analysis to other Zai Lab's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Zai Lab Stock analysis

When running Zai Lab price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is Zai Lab's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai Lab will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
4.4 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Zai Lab is measured differently than its book value, which is the value of Zai Lab that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine Zai Lab value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.